Quantitative densitometry confirmed that within areas of NRTN staining, TH immunoreactivity was comparable to non-Parkinson’s disease age-matched controls whereas in areas absent of NRTN expression, TH-immunoreactivity levels were similar to those seen in non-gene therapy-treated control Parkinson’s disease cases (Fig. 4K). Here, NRTN is linked to Parkinson disease.